Public biobanks: calculation and recovery of costs.
A calculation grid developed by an international expert group was tested across biobanks in six countries to evaluate costs for collections of various types of biospecimens. The assessment yielded a tool for setting specimen-access prices that were transparently related to biobank costs, and the tool was applied across three models of collaborative partnership.
INSERM, National Biobank Infrastructure, Paris, France. INSERM, CRB-Santé and U-991, Pontchaillou Hospital, Rennes, France. bruno.clement@inserm.fr.
Bruno
B
Clément
Centre for Integrated Genomic Medical Research, University of Manchester, Manchester, UK.
Martin
M
Yuille
Institute of Pathology, Medical University of Graz, Graz, Austria.
Kurt
K
Zaltoukal
Institute of Epidemiology, Helmholtz Center, Munich, Germany.
Heinz-Erich
HE
Wichmann
Institute of Epidemiology, Helmholtz Center, Munich, Germany.
Gabriele
G
Anton
Biobank, IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Genoa, Italy.
Barbara
B
Parodi
Biobank, Wroclaw Research Centre, EIT+, Wrocław, Poland.
Lukasz
L
Kozera
Institut Pasteur, Paris, France.
Christian
C
Bréchot
INSERM, National Biobank Infrastructure, Paris, France. Hospital-Integrated Tumor Biobank, Pasteur Hospital, Nice, France.
Paul
P
Hofman
INSERM, National Biobank Infrastructure, Paris, France.
Georges
G
Dagher
D035843:Biomedical Research / Q000191:economics* / Q000458:organization & administration; D002017:Budgets; D003132:Commerce / Q000191:economics* / Q000458:organization & administration; D003299:Cooperative Behavior; D003362:Cost-Benefit Analysis; D005060:Europe; D006801:Humans; D018803:Models, Economic; D017146:Models, Organizational; D013048:Specimen Handling / Q000191:economics*; D014015:Tissue Banks / Q000191:economics* / Q000458:organization & administration; D057188:Workflow